Among the upregulated epigenetic genes were the reader and chromatin remodeller CHD3 [3], the methylated lysine reader DIDO1, the arginine methyltransferase PRMT2, and the lysine methyltransferase PRDM2, not previously described in NASH. This evidence concerns the gene PRDM2 and metabolic dysfunction-associated steatohepatitis.